Fingerprint
Dive into the research topics of 'High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
Martha Arellano, Elliott Winton, Lin Pan, Lisa Lima, Mourad Tighiouart, Kapil Bhalla, Leonard T. Heffner, Jessica Neely, Donald Hutcherson, Morgan McLemore, Amelia Langston, H. Jean Khoury
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations